Citadel Advisors’s Alterity Therapeutics ATHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,488
| Closed | -$15.4K | – | 5961 |
|
|
2024
Q3 | $15.4K | Buy |
+11,488
| New | +$15.4K | ﹤0.01% | 5388 |
|
|
2024
Q2 | – | Sell |
-18,279
| Closed | -$37.5K | – | 5890 |
|
|
2024
Q1 | $37.5K | Buy |
+18,279
| New | +$37.5K | ﹤0.01% | 5390 |
|
|
2022
Q2 | – | Sell |
-2,358
| Closed | -$19K | – | 5980 |
|
|
2022
Q1 | $19K | Buy |
+2,358
| New | +$19K | ﹤0.01% | 6140 |
|
|
2021
Q4 | – | Sell |
-1,176
| Closed | -$15K | – | 6430 |
|
|
2021
Q3 | $15K | Sell |
1,176
-2,622
| -69% | -$33.4K | ﹤0.01% | 6296 |
|
|
2021
Q2 | $49K | Sell |
3,798
-2,703
| -42% | -$34.9K | ﹤0.01% | 6205 |
|
|
2021
Q1 | $94K | Buy |
+6,501
| New | +$94K | ﹤0.01% | 5879 |
|
|
2019
Q1 | – | Sell |
-1,274
| Closed | -$16K | – | 4509 |
|
|
2018
Q4 | $16K | Buy |
+1,274
| New | +$16K | ﹤0.01% | 4324 |
|
|
2017
Q4 | – | Sell |
-1,400
| Closed | -$39K | – | 3845 |
|
|
2017
Q3 | $39K | Buy |
1,400
+193
| +16% | +$5.38K | ﹤0.01% | 3435 |
|
|
2017
Q2 | $28K | Buy |
+1,207
| New | +$28K | ﹤0.01% | 3462 |
|
|
2017
Q1 | – | Sell |
-2,328
| Closed | -$38K | – | 3638 |
|
|
2016
Q4 | $38K | Buy |
+2,328
| New | +$38K | ﹤0.01% | 3347 |
|
|
2016
Q1 | – | Sell |
-623
| Closed | -$27K | – | 3317 |
|
|
2015
Q4 | $27K | Sell |
623
-954
| -60% | -$41.3K | ﹤0.01% | 3559 |
|
|
2015
Q3 | $85K | Buy |
1,577
+916
| +139% | +$49.4K | ﹤0.01% | 3421 |
|
|
2015
Q2 | $46K | Buy |
+661
| New | +$46K | ﹤0.01% | 3445 |
|
|
2015
Q1 | – | Sell |
-353
| Closed | -$35K | – | 3732 |
|
|
2014
Q4 | $35K | Buy |
+353
| New | +$35K | ﹤0.01% | 3485 |
|
|
2014
Q3 | – | Sell |
-528
| Closed | -$72K | – | 3513 |
|
|
2014
Q2 | $72K | Sell |
528
-1,464
| -73% | -$200K | ﹤0.01% | 3053 |
|
|
2014
Q1 | $335K | Buy |
+1,992
| New | +$335K | ﹤0.01% | 2570 |
|